Hospital Universitario 12 de Octubre-ko ikertzaileekin lankidetzan egindako argitalpenak (16)

2023

  1. 30-day readmissions for circulatory system diseases in patients over 75 years with heart failure in Spain (2016-2018)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 8, pp. 655-656

  2. Characteristics and in-hospital mortality of elderly patients with heart failure in Spanish hospitals

    Journal of Geriatric Cardiology, Vol. 20, Núm. 4, pp. 247-255

  3. Clinical features and outcomes of acute heart failure in nonagenarians: Results of a nationwide study

    Geriatrics and Gerontology International

  4. Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction

    Clinical Research in Cardiology

  5. One-year readmissions for circulatory diseases and in-hospital mortality after an index episode of heart failure in elderly patients. A nationwide data from public hospitals in Spain between 2016 and 2018

    Clinical Research in Cardiology, Vol. 112, Núm. 8, pp. 1119-1128

  6. Opinion on the 2021 ESC guidelines on heart failure: a cross-sectional survey of 387 doctors

    REC: CardioClinics, Vol. 58, Núm. 1, pp. 7-15

2022

  1. Impact of blood pressure on management and prognosis of patients treated with sacubitril/valsartan

    REC: CardioClinics, Vol. 57, Núm. 2, pp. 116-122

2021

  1. Initiation and titration of sacubitril/valsartan in different types of centers

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 92-97

  2. Physiopathology, diagnosis, and management of hypomagnesemia in heart failure patients

    REC: CardioClinics

2020

  1. Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan

    Cardiology (Switzerland), Vol. 145, Núm. 5, pp. 275-282

  2. Sacubitril/Valsartan is useful and safe in elderly people with heart failure and reduced ejection fraction. Data from a real-word cohort

    Revista Espanola de Geriatria y Gerontologia, Vol. 55, Núm. 2, pp. 65-69

2019

  1. In-hospital Mortality and Readmissions for Heart Failure in Spain. A Study of Index Episodes and 30-day and 1-year Cardiac Readmissions

    Revista Espanola de Cardiologia, Vol. 72, Núm. 12, pp. 998-1004

  2. Safety of sacubitril/valsartan initiated during hospitalization: data from a non-selected cohort

    ESC Heart Failure, Vol. 6, Núm. 6, pp. 1161-1166

  3. Sex Influence on the Efficacy and Safety of Sacubitril/Valsartan

    Cardiology (Switzerland), Vol. 142, Núm. 2, pp. 73-78

2018

  1. Clinical Profile of a Nonselected Population Treated With Sacubitril/Valsartan Is Different From PARADIGM-HF Trial

    Journal of cardiovascular pharmacology, Vol. 72, Núm. 2, pp. 112-116

2012

  1. Complicaciones cardiovasculares de la neurofibromatosis tipo 1

    Revista Argentina de Cardiologia, Vol. 80, Núm. 5, pp. 419-420